For immediate release |
31 May 2012 |
MedicX Fund Limited
("MedicX Fund", "the Fund" or "the Company")
Sale of ordinary shares out of treasury
MedicX Fund (LSE: MXF), the specialist primary care infrastructure investor in modern, purpose-built, primary healthcare properties in the United Kingdom, announces that today, Thursday 31 May 2012, it sold for cash 6,100,000 ordinary shares of no par value in the Company. The ordinary shares were sold out of treasury by the Company, at a price per share (before expenses) of 77.5 pence.
The net proceeds will be used in further pursuing the investment objectives of the Company.
Following this transaction, the Company has 263,645,780 ordinary shares in issue, of which 7,617,663 are held in treasury. Accordingly, the total voting rights in issue will be 256,028,117.
End
For further information please contact:
MedicX Group: |
+44 (0) 1483 869 500 |
Keith Maddin, Chairman |
|
Mike Adams, Chief Executive Officer |
|
Mark Osmond, Chief Financial Officer |
|
Canaccord Genuity Limited: |
+44 (0) 20 7523 8000 |
Andrew Zychowski/Helen Goldsmith |
|
Buchanan: |
+44 (0) 20 7466 5000 |
Charles Ryland/Suzanne Brocks |
|
MedicX Fund: |
+44 (0) 1481 723 450 |
David Staples, Chairman |
|
Information on MedicX Fund Limited
MedicX Fund Limited ("MXF", the "Fund" or the "Company", or together with its subsidiaries, the "Group") is the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom, listed on the London Stock Exchange, with a portfolio comprising 73 properties.
The Investment Adviser to the Company is MedicX Adviser Ltd, which is authorised and regulated by the Financial Services Authority and is a subsidiary of the MedicX Group. The MedicX Group is a specialist investor, developer and manager of healthcare properties with 27 people operating across the UK.
The Company's website address is www.medicxfund.com. Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website), nor the contents of any website accessible from hyperlinks within this announcement, are incorporated into, or forms part of, this announcement.